While GLP-1 medications have gained attention recently, theres another important part of the conversation: your body already produces GLP-1 on its own
Restoring GHK-Cu through injectable therapy is a powerful intervention with effects that go far beyond topical skincare
Intervention Studies evaluating GLP-1 receptor agonists (Liraglutide, Lixisenatide, Semaglutide, Exenatide, Albiglutide, Dulaglutide, Efpeglenatide)
GSH is able to reduce the disulfide bonds and hydroperoxides by glutathione peroxidases (GPxs) or promote the glutathionylation at cysteine residues by Glutathione STransferase (GST) to protect protein from oxidation
Serious adverse events and complications of these medications may include Gastroparesis (paralysis of the stomach), NAION vision loss, Ileus, Pancreatitis, Wernickes Encephalopathy, Bowel obstruction (blocked intestine), Malnutrition requiring hospitalization, and Pulmonary aspiration while under anesthesia or during surgery
10.1186/s13023014-01308 96
